270 related articles for article (PubMed ID: 27783153)
1. Epidermal hydrogen peroxide is not increased in lesional and non-lesional skin of vitiligo.
Zailaie MZ
Arch Dermatol Res; 2017 Jan; 309(1):31-42. PubMed ID: 27783153
[TBL] [Abstract][Full Text] [Related]
2. Basic evidence for epidermal H2O2/ONOO(-)-mediated oxidation/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS.
Schallreuter KU; Salem MA; Holtz S; Panske A
FASEB J; 2013 Aug; 27(8):3113-22. PubMed ID: 23629861
[TBL] [Abstract][Full Text] [Related]
3. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.
Schallreuter KU; Moore J; Wood JM; Beazley WD; Gaze DC; Tobin DJ; Marshall HS; Panske A; Panzig E; Hibberts NA
J Investig Dermatol Symp Proc; 1999 Sep; 4(1):91-6. PubMed ID: 10537016
[TBL] [Abstract][Full Text] [Related]
5. Increased systemic and epidermal levels of IL-17A and IL-1β promotes progression of non-segmental vitiligo.
Bhardwaj S; Rani S; Srivastava N; Kumar R; Parsad D
Cytokine; 2017 Mar; 91():153-161. PubMed ID: 28082234
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo.
Spencer JD; Gibbons NC; Rokos H; Peters EM; Wood JM; Schallreuter KU
J Invest Dermatol; 2007 Feb; 127(2):411-20. PubMed ID: 16946714
[TBL] [Abstract][Full Text] [Related]
7. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
8. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
9. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
[TBL] [Abstract][Full Text] [Related]
10. Local Epidermal Endocrine Estrogen Protects Human Melanocytes against Oxidative Stress, a Novel Insight into Vitiligo Pathology.
Yamamoto A; Yang L; Kuroda Y; Guo J; Teng L; Tsuruta D; Katayama I
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383933
[TBL] [Abstract][Full Text] [Related]
11. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
[TBL] [Abstract][Full Text] [Related]
13. Autologous epidermal grafting with PUVA-irradiated donor skin for the treatment of vitiligo.
Lee AY; Jang JH
Int J Dermatol; 1998 Jul; 37(7):551-4. PubMed ID: 9679700
[TBL] [Abstract][Full Text] [Related]
14. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo.
Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI
G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of oxidative stress in vitiligo.
Schallreuter KU
Skin Pharmacol Appl Skin Physiol; 1999; 12(3):132-8. PubMed ID: 10393521
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
17. Senescence in the lesional fibroblasts of non-segmental vitiligo patients.
Rani S; Bhardwaj S; Srivastava N; Sharma VL; Parsad D; Kumar R
Arch Dermatol Res; 2017 Mar; 309(2):123-132. PubMed ID: 28078437
[TBL] [Abstract][Full Text] [Related]
18. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
19. TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress.
Kang P; Zhang W; Chen X; Yi X; Song P; Chang Y; Zhang S; Gao T; Li C; Li S
Free Radic Biol Med; 2018 Oct; 126():259-268. PubMed ID: 30138713
[TBL] [Abstract][Full Text] [Related]
20. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]